In one person with severe obesity and type 2 diabetes taking tirzepatide, a specific pattern of brainwave activity in a region linked to reward processing occurred at the same time as intense...
Mechanism
Synthesis from 1 study
The drug changes how brain cells in the reward area talk to each other, making them sync up in a slow rhythm that makes food thoughts feel overpowering. It takes weeks for this brain change to turn into intense cravings, even though the drug is still working.
Most probable mechanism
The weight-loss drug changes how brain cells in the reward center communicate, making them fire in a slow, synchronized rhythm. This rhythm makes thoughts about food feel more urgent and hard to ignore, even when the drug is working to reduce hunger. It takes weeks for this brain change to turn into strong food cravings.
Tirzepatide crosses the blood-brain barrier and binds to GLP-1 and/or GIP receptors expressed on neurons or glial cells in the nucleus accumbens
Receptor binding alters neuronal membrane potential or synaptic transmission, increasing synchronization of low-frequency (≤7 Hz) oscillatory activity in the nucleus accumbens
Increased delta-theta oscillations enhance the salience of food-related stimuli and amplify motivational drive through mesolimbic circuitry
Neuroadaptive changes in downstream mesocorticolimbic circuits delay the behavioral manifestation of increased food preoccupation by approximately 7 weeks
Evidence from Studies
Supporting (1)
Community contributions welcome
Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.